期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 453, 期 1, 页码 65-79出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2012.04.066
关键词
Amorphous drug; Stability; Co-amorphous; Mesoporous; Solubility; Dissolution
资金
- Academy of Finland [136699]
- Magnus Ehrnrooth Foundation [KE2010n14]
- Saastamoinen Foundation
- Academy of Finland (AKA) [136699, 136699] Funding Source: Academy of Finland (AKA)
The number of active pharmaceutical substances having high therapeutic potential but low water solubility is constantly increasing, making it difficult to formulate these compounds as oral dosage forms. The solubility and dissolution rate, and thus potentially the bioavailability, of these poorly water-soluble drugs can be increased by the formation of stabilized amorphous forms. Currently, formulation as solid polymer dispersions is the preferred method to enhance drug dissolution and to stabilize the amorphous form of a drug. The purpose of this review is to highlight emerging alternative methods to amorphous polymer dispersions for stabilizing the amorphous form of drugs. First, an overview of the properties and stabilization mechanisms of amorphous forms is provided. Subsequently, formulation approaches such as the preparation of co-amorphous small-molecule mixtures and the use of mesoporous silicon and silica-based carriers are presented as potential means to increase the stability of amorphous pharmaceuticals. (c) 2012 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据